S-1 · primary and resale
Issued 2024
Proposed maximum
Shares registered
- Filed
- Effective
CURX$5.92+1.20%
Curanex Pharmaceuticals Inc
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$9.28M
Float & O/S:
Inst Own:
DilutionScan read 9 of Curanex Pharmaceuticals Inc's SEC filings and found 1 convertible, 1 S-1 registration and 2 completed offerings on file for CURX. The latest dilution event on file is an offering on Sep 12, 2025. Analysis updated Sep 11, 2026.
Signal8 Summary
Raise routes on file: no active ATM, effective shelf, S-1 or equity line in the filings read · latest dilution event 417 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Sep 12, 2025 · Offering
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Completed
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Public offering
Issued 2025
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Public offering
Issued 2025
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your CURX trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
